Healthy Skepticism Library item: 18852
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
 Spurling G
 Time to put education to tender 
 MJA InSight 2010 Nov 8
 
http://www.mjainsight.com.au/view?post=Geoffrey+Spurling:+Time+to+put+education+to+tender&post_id=1520
Full text:	
IT is time the medical profession stopped relying so heavily on the  
pharmaceutical industry for its ongoing education about medications.
I have been involved in recent research that should convince  
policymakers the time has come to trial a system where education and  
promotion of medications to physicians is put out to competitive  
tender with measurable outcomes such as adherence to prescribing  
guidelines.
The promotion of pharmaceuticals to doctors is a huge industry with US 
$57 billion spent on promotion in 2004 in the US alone.
Australian data suggest that pharmaceutical companies spend more than  
$10 000 for each Australian GP that sales representatives visit each  
year.
The industry claims this promotion is educational and beneficial to  
prescribers. Many doctors deny that it influences their prescribing.
The recent research I was involved with was a systematic review of all  
the medical literature in the past 40+ years.
We started with more than 7000 articles and finally included 58 which  
answered the research question regarding the impact of pharmaceutical  
information on prescribing.
The clear conclusion from this review is that the medical literature  
does not support claims of benefits for doctors in using  
pharmaceutical promotion.
The other clear conclusion is that many studies found associations  
between promotion and increased frequency of prescribing, suggesting  
that doctors are influenced by pharmaceutical promotion at least some  
of the time.
Our review does not exclude the possibility that pharmaceutical  
company promotion benefits patients in certain situations.
One study found that residents attending a sponsored education session  
were more likely to prescribe the sponsoring company’s medication when  
it was appropriate but also when it was inappropriate.
Other studies looking specifically at quality of prescribing as an  
outcome found that doctors seeing sales representatives were less  
likely to adhere to prescribing guidelines and less likely to  
prescribe rationally.
One study found that physicians with high prescribing costs were more  
than three times more likely to see pharmaceutical representatives  
once a week and were more likely to read promotional mail or journal  
advertisements from pharmaceutical companies than physicians with low  
prescribing costs.
Our study concluded that “The findings support the case for reforms to  
reduce negative influence to prescribing from pharmaceutical promotion.”
More prescribing of pharmaceutical products does not always equal  
better health, as any practitioner who prescribed Vioxx would know.
We argue that promotion should be regulated and doctors should be  
provided with more resources to aid their therapeutic decision making.
A tender system of offering education could be open to pharmaceutical  
companies but they might be competing with universities or specialist  
colleges.
This would give pharmaceutical companies the incentive to promote  
their products in a way that ensured physicians prescribed rationally  
in addition to the incentive of providing a return on investment to  
their shareholders.
I would like to see research evaluating this type of tender, similar  
to what occurs with competitive research grants and other tendering  
processes.
There also needs to be an emphasis on educating medical students and  
junior doctors about the value of independent sources of information.
Remember that, as doctors, we are not invulnerable to promotion from  
pharmaceutical companies and that the sales representatives are there  
for the company’s shareholders as much as for us.
We would save time by using independent sources of information and our  
patients are likely to support reforms that ensure this occurs.
 








 



